Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.11
-0.10 (-1.39%)
Oct 29, 2024, 4:00 PM EDT - Market closed
MRVI Revenue
Maravai LifeSciences Holdings had revenue of $73.40M in the quarter ending June 30, 2024, with 6.51% growth. This brings the company's revenue in the last twelve months to $278.59M, down -48.78% year-over-year. In the year 2023, Maravai LifeSciences Holdings had annual revenue of $288.95M, down -67.28%.
Revenue (ttm)
$278.59M
Revenue Growth
-48.78%
P/S Ratio
3.40
Revenue / Employee
$428,592
Employees
650
Market Cap
1.01B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owens & Minor | 10.53B |
Avanos Medical | 682.40M |
Evolus | 237.26M |
Prothena Corporation | 217.25M |
Aurinia Pharmaceuticals | 207.11M |
Arcutis Biotherapeutics | 132.06M |
Mesoblast | 5.90M |
IGM Biosciences | 2.91M |
MRVI News
- 14 days ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 - GlobeNewsWire
- 2 months ago - Exclusive: Repligen in bid for reagent vendor Maravai, sources say - Reuters
- 2 months ago - Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule - GlobeNewsWire
- 2 months ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 - GlobeNewsWire
- 4 months ago - Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report - GlobeNewsWire
- 4 months ago - Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics - Accesswire
- 6 months ago - TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center - Business Wire